img

Post-pandemic Era-Global Bio-protein Drug Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin


Published on: 2024-01-04 | No of Pages : 121 | Industry : Medical Devices & Consumables Research Center

Publisher : X | Format : PDF

Post-pandemic Era-Global Bio-protein Drug Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

MRAResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Bio-protein Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bio-protein Drug Market by MRAResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Bio-protein Drug Market?
Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy's Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.
...
Major Type of Bio-protein Drug Covered in MRAResearch report
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Application Segments Covered in MRAResearch Market
Pharma and Biotech Companies
CROs
Academics

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Bio-protein Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.1.2 Therapeutic Proteins -Product Introduction and Major Manufacturers
1.1.3 Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Bio-protein Drug Status and Prospect (2015-2026)
2.1.1 China Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Bio-protein Drug Status and Prospect (2015-2026)
2.2.1 EU Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Bio-protein Drug Status and Prospect (2015-2026)
2.3.1 USA Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Bio-protein Drug Status and Prospect (2015-2026)
2.4.1 Japan Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Bio-protein Drug Status and Prospect (2015-2026)
2.5.1 India Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Bio-protein Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Bio-protein Drug Status and Prospect (2015-2026)
2.7.1 South America Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Bio-protein Drug Status and Prospect (2015-2026)
2.8.1 Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.8.2 Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Bio-protein Drug Market Assessment by Segment
3.1 Global Bio-protein Drug Capacity and Growth Rate
3.2 Global Bio-protein Drug Sales by Type
3.3 Global Bio-protein Drug Sales Revenue by Type
3.4 Global Bio-protein Drug Consumption by Application
4 Global Bio-protein Drug Market Assessment by Regions
4.1 Global Bio-protein Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Bio-protein Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Bio-protein Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Bio-protein Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Bio-protein Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Bio-protein Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Bio-protein Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Bio-protein Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Bio-protein Drug Competitive Analysis
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Profiles
7.1.2 Abbott Laboratories Product Introduction
7.1.3 Abbott Laboratories Bio-protein Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Bayer AG
7.2.1 Bayer AG Company Profiles
7.2.2 Bayer AG Product Introduction
7.2.3 Bayer AG Bio-protein Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Profiles
7.3.2 Eli Lilly and Company Product Introduction
7.3.3 Eli Lilly and Company Bio-protein Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Amgen Inc.
7.4.1 Amgen Inc. Company Profiles
7.4.2 Amgen Inc. Product Introduction
7.4.3 Amgen Inc. Bio-protein Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Biocon Ltd.
7.5.1 Biocon Ltd. Company Profiles
7.5.2 Biocon Ltd. Product Introduction
7.5.3 Biocon Ltd. Bio-protein Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Dr. Reddy's Laboratories
7.6.1 Dr. Reddy's Laboratories Company Profiles
7.6.2 Dr. Reddy's Laboratories Product Introduction
7.6.3 Dr. Reddy's Laboratories Bio-protein Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Roche
7.7.1 Roche Company Profiles
7.7.2 Roche Product Introduction
7.7.3 Roche Bio-protein Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Fresenius kabi
7.8.1 Fresenius kabi Company Profiles
7.8.2 Fresenius kabi Product Introduction
7.8.3 Fresenius kabi Bio-protein Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Profiles
7.9.2 GlaxoSmithKline Product Introduction
7.9.3 GlaxoSmithKline Bio-protein Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Profiles
7.10.2 Johnson & Johnson Product Introduction
7.10.3 Johnson & Johnson Bio-protein Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Merck
7.12 Novartis AG
7.13 Panacea Biotec
7.14 ProBioGen AG
7.15 Sanofi
7.16 Reliance Life Science Pvt. Ltd.
8 Conclusion


List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Bio-protein Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Bio-protein Drug Sales (K Unit) by Type (2015-2026)
Figure Global Bio-protein Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Bio-protein Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Bio-protein Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Bio-protein Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Bio-protein Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Bio-protein Drug Sales (K Unit) by Application (2015-2026)
Figure China Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Bio-protein Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Bio-protein Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Bio-protein Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Bio-protein Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Bio-protein Drug Sales (Unit) by Type (2015-2026)
Figure Global Bio-protein Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Bio-protein Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Bio-protein Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Bio-protein Drug Consumption (Unit) by Application (2015-2026)
Figure Global Bio-protein Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Bio-protein Drug Production (K Unite) by Regions (2015-2020)
Table Global Bio-protein Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Bio-protein Drug Production Share by Regions (2019-2020)
Table Global Bio-protein Drug Sales (K Unite) by Regions (2015-2020)
Table Global Bio-protein Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Bio-protein Drug Sales Share by Regions (2019-2020)
Table Global Bio-protein Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Bio-protein Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Bio-protein Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Bio-protein Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Bio-protein Drug
Figure Cost Structure of Bio-protein Drug in 2020
Table Global Bio-protein Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Bio-protein Drug Capacity Share of Manufacturers (2019-2020)
Table Global Bio-protein Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Bio-protein Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Bio-protein Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Bio-protein Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Bio-protein Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Abbott Laboratories Profiles
Table ????Abbott Laboratories Bio-protein Drug Product Introduction
Table ????Abbott Laboratories Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Abbott Laboratories SWOT Analysis
Table ????Bayer AG Profiles
Table ????Bayer AG Bio-protein Drug Product Introduction
Table ????Bayer AG Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bayer AG SWOT Analysis
Table ????Eli Lilly and Company Profiles
Table ????Eli Lilly and Company Bio-protein Drug Product Introduction
Table ????Eli Lilly and Company Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eli Lilly and Company SWOT Analysis
Table ????Amgen Inc. Profiles
Table ????Amgen Inc. Bio-protein Drug Product Introduction
Table ????Amgen Inc. Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Amgen Inc. SWOT Analysis
Table ????Biocon Ltd. Profiles
Table ????Biocon Ltd. Bio-protein Drug Product Introduction
Table ????Biocon Ltd. Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Biocon Ltd. SWOT Analysis
Table ????Dr. Reddy's Laboratories Profiles
Table ????Dr. Reddy's Laboratories Bio-protein Drug Product Introduction
Table ????Dr. Reddy's Laboratories Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dr. Reddy's Laboratories SWOT Analysis
Table ????Roche Profiles
Table ????Roche Bio-protein Drug Product Introduction
Table ????Roche Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Roche SWOT Analysis
Table ????Fresenius kabi Profiles
Table ????Fresenius kabi Bio-protein Drug Product Introduction
Table ????Fresenius kabi Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Fresenius kabi SWOT Analysis
Table ????GlaxoSmithKline Profiles
Table ????GlaxoSmithKline Bio-protein Drug Product Introduction
Table ????GlaxoSmithKline Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????GlaxoSmithKline SWOT Analysis
Table ????Johnson & Johnson Profiles
Table ????Johnson & Johnson Bio-protein Drug Product Introduction
Table ????Johnson & Johnson Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Johnson & Johnson SWOT Analysis
Table ????Merck Profiles
Table ????Merck Bio-protein Drug Product Introduction
Table ????Merck Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Merck SWOT Analysis
Table ????Novartis AG Profiles
Table ????Novartis AG Bio-protein Drug Product Introduction
Table ????Novartis AG Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novartis AG SWOT Analysis
Table ????Panacea Biotec Profiles
Table ????Panacea Biotec Bio-protein Drug Product Introduction
Table ????Panacea Biotec Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Panacea Biotec SWOT Analysis
Table ????ProBioGen AG Profiles
Table ????ProBioGen AG Bio-protein Drug Product Introduction
Table ????ProBioGen AG Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????ProBioGen AG SWOT Analysis
Table ????Sanofi Profiles
Table ????Sanofi Bio-protein Drug Product Introduction
Table ????Sanofi Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sanofi SWOT Analysis
Table ????Reliance Life Science Pvt. Ltd. Profiles
Table ????Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Introduction
Table ????Reliance Life Science Pvt. Ltd. Bio-protein Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Reliance Life Science Pvt. Ltd. SWOT Analysis